Location History:
- Seocho-gu, KR (2018)
- Seoul, KR (2017 - 2020)
Company Filing History:
3 out of 1,114 
1 out of 15 Years Active: 2017-2020
Title: Eun Jung Baek: Innovator in Cancer Treatment
Introduction
Eun Jung Baek is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 4 patents, Baek is recognized for his work in developing peptides that have anticancer activity.
Latest Patents
Baek's latest patents include a peptide that binds to the transcription factor CP2c, which plays a crucial role in cancer cell activity. This peptide, represented by SEQ ID NO: 1: Asn-Tyr-Pro-Gln-Arg-Pro, is part of a pharmaceutical composition and dietary supplement designed for preventing and treating cancer. The invention highlights the peptide's ability to pass through cell membranes with high stability, specifically binding to CP2c and inhibiting its DNA binding ability. This mechanism disrupts CP2c-mediated transcriptional activity in cancer cells, making it a promising candidate for targeted cancer treatment and prevention.
Career Highlights
Throughout his career, Eun Jung Baek has worked with various institutions, including the Industry-University Cooperation Foundation at Hanyang University. His research has focused on innovative methods for cancer treatment and cell expansion techniques.
Collaborations
Baek has collaborated with notable colleagues, including Eun-Mi Lee and Chul Geun Kim, contributing to advancements in his field.
Conclusion
Eun Jung Baek's work exemplifies the intersection of innovation and healthcare, particularly in the fight against cancer. His patented inventions hold the potential to significantly impact cancer treatment and prevention strategies.